Loading organizations...
Loading organizations...
Developer of diagnostic technology.
Enzyre has raised $13.5M across 2 funding rounds.
Enzyre has raised $13.5M in total across 2 funding rounds.
Enzyre has raised $13.5M in total across 2 funding rounds.
Enzyre's investors include Pieter Rhemrev, Demcon Investment, Karel Kubias, Novalis Biotech, Takeda Ventures, Wim van Criekinge.
Enzyre has raised $13.5M across 2 funding rounds. Most recently, it raised $11.9M Series A in November 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 2, 2022 | $11.9M Series A | Pieter Rhemrev | Demcon Investment, Karel Kubias, Novalis Biotech, Takeda Ventures |
| Jul 27, 2020 | $1.6M Other Equity | Wim van Criekinge |